Metropolis Healthcare informs about updates on acquisition

17 Jun 2025 Evaluate
In continuation to intimation dated May 31, 2025, Metropolis Healthcare has informed that Scientific Metropolis Pathology (formerly known as Metropolis Clinical Pathology), a subsidiary of Metropolis Healthcare, has acquired the entire business of ‘Dr. Ashok Kumar Sharma’s Scientific Pathology’, a sole proprietorship firm of Dr. Ashok Kumar Sharma as a going concern, effective June 16, 2025, as per the terms agreed under the Business Transfer Agreement (‘BTA’). The other terms and conditions, including deferred consideration, will be executed in accordance with the BTA. Consequent to the above transfer, the operations of the ‘Dr. Ashok Kumar Sharma’s Scientific Pathology’ are now being carried out under Scientific Metropolis Pathology, effective June 16, 2025.

The above information is a part of company’s filings submitted to BSE.

Metropolis Health. Share Price

433.05 2.00 (0.46%)
30-Mar-2026 14:58 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7398.40
Max Healthcare Inst 965.55
Narayana Hrudayalay 1609.10
Aster DM Healthcare 656.05
Global Health 963.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×